Breast cancer heterogeneity: Mechanisms, proofs, and implications

Journal of Cancer

Volumn 1, Issue 1, 2010, Pages 6-13

  Hsiao, Yi Hsuan ^a,b   Chou, Ming Chih ^a   Fowler, Carol ^c   Mason, Jeffrey T ^c   Man, Yan Gao ^c,d  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^d JILIN UNIVERSITY   (China)

Author keywords

Breast cancer heterogeneity; Clinical implication; Hypothesized model; Mechanism

Indexed keywords

CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR 1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TAMOXIFEN; TRASTUZUMAB; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CLASSIFICATION; CANCER INVASION; CANCER PROGNOSIS; CELL ISOLATION; DISEASE ACTIVITY; DISEASE COURSE; GENE EXPRESSION; GENETIC HETEROGENEITY; HUMAN; IMMUNOHISTOCHEMISTRY;

EID: 79952469959     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.1.6     Document Type: Article

References (20)

1. Rossen PP. Rosen's breast pathology. Philadelphia, PA: Lippncott Williams & Wilkins. 2001.
2. Tavassoli FA. Pathology of the Breast. New York: Elsevier. 1992.
3. Mathelin C, Annane K, Treisser A, Chenard MP, Tomaseeto C, Bellocq JP, Rio MC. Pregnancy and post-partum breast cancer: a prospective study. Anticancer Res 2008; 28(4C): 2447-2452.
4. Rodriguez AO, Chew H, Cress R, Xing G, McEivy S, Danielsen B, Smith L. Evidence of poorer survival in pregnancy-associated breast cancer. Obstet Gynecol 2008; 112(1):71-78.
5. Mego M, DeGiorgi U, Hsu L, Ueno NT, Valero V, Jackson S, et al. Circulating tumor cells in metastatic inflammatory breast cancer. Ann Oncol. 2009; 20(11):1824-1828.
6. Man YG, Schwartz A, Levine PH, Teal C, Berg PE. BP1, a putative signature marker for inflammatory breast cancer and tumor aggressiveness. Cancer Biomark. 2009; 5(1):9-17.
7. Cianfrocca M, Gradishar W. New molecular classification of breast cancer. CA Cancer J Clin 2009; 59(5):303-313.
8. Tang P, Skinner KA, Hicks DG. Molecular classification of breast carcinomas by immunohistochemical analysis: are we ready? Diagn Mol Pathol. 2009;18(3):125-32.
9. Weigelt B, Mackay A, A'hern R, Natrajan R, Tan DS, Dowsett M, et al.. Breast cancer molecular profiling with single sample predictors: a retrospective analysis. Lancet Oncol 2010; 11(4):339-349.
10. Cohnheim J. Congenitales, quergestreiftes Muskelsarcom der Niere. Virchows Archiv fur Pathologische and Physiologic and fur Klinische Medizin 1875; 65:64-69.
11. Nowell PC. The clonal evolution of tumor cell populations. Science 1976; 194:23-28.
12. Zhang XC, Hashemi SS, Yousefi M, Gao CL, Sheng J, Mason J, Man YG. Atypical expression of c-erbB2 in cell clusters overlying focally disrupted breast myoepithelial cell layers: a potential sign for increasing cell motility and invasion. Int J Biol Sci 2008; 4:259-269.
13. Man YG, Ball WD, Culp AJ, Hand AR, Moreira JE. Persistence of a perinatal cellular phenotype in the ducts of adult glands. J Histochem Cytochem 1995; 43(12):1203-1215.
14. Man YG, Ball WD, Marchetti L, Hand AR. Contributions of intercalated duct cells to normal parenchyma of submandibular glands of adult rats. Anat Rec. 2001;263(2):202-14.
15. Man YG, Tai L, Barner R, Vang R, Saenger JS, Shekitka KM, et al. Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion. Breast Cancer Res 2003; 5: R231-241.
16. Yousefi M, Mattu R, Gao C, Man YG. Mammary ducts with and without focal myoepithelial cell layer disruptions show a different frequency of white blood cell infiltration and growth pattern: Implications for tumor progression and invasion. AIMM 2005; 13:30-37.
17. Man YG, Zhang Y, Shen T, Vinh TN, Zeng X, Tauler J, et al. cDNA expression profiling identifies elevated expressions of tumor progression and invasion related genes in cell clusters of in situ breast tumors. Breast Cancer Res Treat 2005; 89:199-208.
18. Man YG, Zhao CQ, Wang J. Breast tumor cell clusters and their budding derivatives show different immunohistochemical profiles during stromal invasion: implications for hormonal and drug therapies. Cancer Therapy 2006; 4: 193-204.
19. Man YG, Shen T, Weisz J, Berg PE, Schwartz AM, Mulshine JL, Sang QXA, Nieburgs HE. A subset of in situ breast tumor cell clusters lacks expression of proliferation and progression related markers but shows signs of stromal and vascular invasion. Cancer Detect Prev 2005; 29:323-331.
20. Man YG, Nieburgs HE. A subset of cell clusters with malignant features in morphologically normal and hyperplastic breast tissues. Cancer Detect Prev 2006; 30 (3): 239-247.